by editor | Oct 5, 2011 | Latest Spotlights, Medical Stocks
(Dallas, TX. – October 5, 2011) StockGuru Shines its Spotlight on BioCurex Inc. (OTCBB: BOCX). The Company announced yesterday that its article entitled: “Increased AFP-Receptor (RECAF™) Values in the Serum of Patients With Early Stages of Breast...
by editor | Sep 12, 2011 | Latest Spotlights, Medical Stocks
Dallas, Texas (September 12, 2011) – StockGuru Shines its Spotlight on BioCurex Inc. (OTCBB: BOCX) which announced results indicating that its RECAF blood test for cancer can prevent 70% of unnecessary prostate biopsies. In a study to be presented at the ISOBM...
by editor | Aug 26, 2011 | Latest Spotlights, Medical Stocks
Dallas, Texas (August 26, 2011) – StockGuru Shines its Spotlight on BioCurex Inc. (OTCBB: BOCX) — yesterday announced that the Review Board for the 39th Annual Meeting of the International Society for Oncology and Biomarkers (ISOBM), has accepted two...